Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Duke-NUS and Japan-based IPGaia Announce Partnership to Accelerate Innovation in Drug Discovery
Details : Through the agreement, Duke-NUS will propose drug targets to IPG, which will, in turn, identify and develop lead compounds with the goal of licensing clinic-ready candidates to pharmaceutical companies.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
July 11, 2023
Reset All
